GE HealthCare Technologies Inc. $GEHC Shares Purchased by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,114 shares of the company’s stock after purchasing an additional 826 shares during the period. Wilmington Savings Fund Society FSB’s holdings in GE HealthCare Technologies were worth $749,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in GEHC. Sequoia Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 20.9% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 18,297 shares of the company’s stock valued at $1,355,000 after acquiring an additional 3,166 shares in the last quarter. LRI Investments LLC increased its holdings in GE HealthCare Technologies by 60.5% during the 2nd quarter. LRI Investments LLC now owns 1,112 shares of the company’s stock valued at $82,000 after acquiring an additional 419 shares in the last quarter. OFI Invest Asset Management increased its holdings in GE HealthCare Technologies by 40.3% during the 2nd quarter. OFI Invest Asset Management now owns 1,277 shares of the company’s stock valued at $95,000 after acquiring an additional 367 shares in the last quarter. Concurrent Investment Advisors LLC increased its holdings in GE HealthCare Technologies by 31.6% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 8,529 shares of the company’s stock valued at $632,000 after acquiring an additional 2,049 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at about $210,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Barclays assumed coverage on shares of GE HealthCare Technologies in a report on Monday. They set an “equal weight” rating and a $86.00 target price for the company. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday. BTIG Research raised their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a report on Monday. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $73.38 on Friday. The company has a market cap of $33.50 billion, a PE ratio of 15.04, a price-to-earnings-growth ratio of 2.80 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The company has a 50-day simple moving average of $74.47 and a 200-day simple moving average of $72.12.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. GE HealthCare Technologies’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.